Target intelligence / Profile preview

Solute carrier family 25 member 5 pseudogene 5 (SLC25A5P5)

Target
SLC25A5P5
Molecular classification
Other (Pseudogene), Solute carrier family (non-coding)
01

Overview

The SLC25A5P5 gene, also known as solute carrier family 25 member 5 pseudogene 5, is classified as a pseudogene derived from the coding gene SLC25A5, which encodes the ADP/ATP translocase in mitochondria[2][3][4]. SLC25A5P5 itself does not produce a functional protein and is not implicated in any known biological processes or diseases. It can be distinguished from the functional SLC25A5 gene, also known as ANT2, which is important in mitochondrial energy metabolism, apoptosis, and has potential roles in cancer and neurological disorders[1][5][6][7]. The existence of SLC25A5P5 reflects normal genomic processes resulting in non-coding DNA segments related to protein-coding genes; these pseudogenes are not targets for pharmacological modulation or clinical intervention. Note: If you require information about the functional target, search for "Solute carrier family 25 member 5" (SLC25A5 or ANT2), not the pseudogene SLC25A5P5. The pseudogene itself is not a receptor, enzyme, transporter, or recognized therapeutic target; some sources may list it among aliases or gene families, but only the coding homolog (SLC25A5) has biological and clinical significance[1][5][7].

Other names
ANTP5TCAG_29001adenine nucleotide translocator pseudogene 5 (clone 19)solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 5 pseudogene 5SLC25A5P5
02

Mechanism of action

None (no drugs or endogenous ligands act on this pseudogene)

03

Biological functions

None (does not code for a functional protein)
04

Disease associations

None (no evidence of disease association for SLC25A5P5 pseudogene)
05

Safety considerations

None (not used in therapeutic interventions)
06

Interacting drugs

None (not a druggable target)
07

Biomarkers

None reported

Beyond the preview

Go deeper on Solute carrier family 25 member 5 pseudogene 5 (SLC25A5P5).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Solute carrier family 25 member 5 pseudogene 5 (SLC25A5P5).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call